BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28740336)

  • 21. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.
    Xu X; Yu T; Shi J; Chen X; Zhang W; Lin T; Liu Z; Wang Y; Zeng Z; Wang C; Li M; Liu C
    J Biol Chem; 2014 Mar; 289(13):8881-90. PubMed ID: 24532795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and the regulation of Wnt/beta-catenin signaling and innate immunity in colorectal cancer.
    Byers S; Shah S
    Nutr Rev; 2007 Aug; 65(8 Pt 2):S118-20. PubMed ID: 17867386
    [No Abstract]   [Full Text] [Related]  

  • 24. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
    Ortega P; Morán A; de Juan C; Frías C; Hernández S; López-Asenjo JA; Sánchez-Pernaute A; Torres A; Iniesta P; Benito M
    Clin Cancer Res; 2008 Feb; 14(4):995-1001. PubMed ID: 18281531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells.
    Thomas M; Bayha C; Vetter S; Hofmann U; Schwarz M; Zanger UM; Braeuning A
    Mol Pharmacol; 2015 Jun; 87(6):1013-20. PubMed ID: 25824487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
    Rahmani F; Avan A; Hashemy SI; Hassanian SM
    J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Wnt and β-catenin Expression in Advanced Colorectal Cancer.
    Yoshida N; Kinugasa T; Ohshima K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y
    Anticancer Res; 2015 Aug; 35(8):4403-10. PubMed ID: 26168479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
    Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
    J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
    Raghu D; Karunagaran D
    J Nat Prod; 2014 May; 77(5):1130-4. PubMed ID: 24828199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
    Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
    Bahrami A; Amerizadeh F; ShahidSales S; Khazaei M; Ghayour-Mobarhan M; Sadeghnia HR; Maftouh M; Hassanian SM; Avan A
    J Cell Biochem; 2017 Aug; 118(8):1979-1983. PubMed ID: 28109136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis.
    Zhang J; Tsoi H; Li X; Wang H; Gao J; Wang K; Go MY; Ng SC; Chan FK; Sung JJ; Yu J
    Gut; 2016 Sep; 65(9):1482-93. PubMed ID: 26071132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis.
    Anwar M; Kochhar R; Singh R; Bhatia A; Vaiphei K; Mahmood A; Mahmood S
    Mol Carcinog; 2016 Nov; 55(11):1627-1638. PubMed ID: 26373808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.